Rafferty Asset Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$274K Buy
+118,683
New +$274K ﹤0.01% 998
2025
Q1
Sell
-252,257
Closed -$436K 1144
2024
Q4
$436K Buy
+252,257
New +$436K ﹤0.01% 935